History of Vaccibody Norway - Vaccibody.com - Vaccine company
page-template-default,page,page-id-2064,bridge-core-2.4.3,qode-page-transition-enabled,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-25.7,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.6.0,vc_responsive


Vaccibody AS is a privately held vaccine company based on the technology conceived and developed at the University of Oslo and Oslo University Hospital in the laboratory of professor Bjarne Bogen, with contributions from professor Inger Sandlie.


Vaccibody AS has developed a unique and innovative vaccine platform with the aim to treat and prevent cancer as well as infectious diseases. Through its innovative design Vaccibody’s proprietary vaccine platform generates fast, strong, long-lasting and broad antibody and T cell responses leading to remarkably potent vaccines.